![]() |
|||||||
|
Fusion Protein:FARP1-NME1 |
Fusion Gene and Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: FARP1-NME1 | FusionPDB ID: 29378 | FusionGDB2.0 ID: 29378 | Hgene | Tgene | Gene symbol | FARP1 | NME1 | Gene ID | 10160 | 6023 |
Gene name | FERM, ARH/RhoGEF and pleckstrin domain protein 1 | RNA component of mitochondrial RNA processing endoribonuclease | |
Synonyms | CDEP|FARP1-IT1|PLEKHC2|PPP1R75 | CHH|NME1|RMRPR|RRP2 | |
Cytomap | 13q32.2 | 9p13.3 | |
Type of gene | protein-coding | ncRNA | |
Description | FERM, ARHGEF and pleckstrin domain-containing protein 1FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)FERM, RhoGEF and pleckstrin domain-containing protein 1PH domain-containing family C member 2chondrocyte-derived ezrin-li | - | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9Y4F1 Main function of 5'-partner protein: FUNCTION: Functions as guanine nucleotide exchange factor for RAC1. May play a role in semaphorin signaling. Plays a role in the assembly and disassembly of dendritic filopodia, the formation of dendritic spines, regulation of dendrite length and ultimately the formation of synapses (By similarity). {ECO:0000250}. | P15531 Main function of 5'-partner protein: FUNCTION: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Possesses nucleoside-diphosphate kinase, serine/threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. Involved in cell proliferation, differentiation and development, signal transduction, G protein-coupled receptor endocytosis, and gene expression. Required for neural development including neural patterning and cell fate determination. During GZMA-mediated cell death, works in concert with TREX1. NME1 nicks one strand of DNA and TREX1 removes bases from the free 3' end to enhance DNA damage and prevent DNA end reannealing and rapid repair. {ECO:0000269|PubMed:12628186, ECO:0000269|PubMed:16818237, ECO:0000269|PubMed:8810265}. | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000319562, ENST00000376581, ENST00000376586, ENST00000595437, ENST00000593990, | ENST00000013034, ENST00000336097, ENST00000393196, ENST00000480143, ENST00000511355, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 19 X 13 X 10=2470 | 3 X 4 X 3=36 |
# samples | 22 | 4 | |
** MAII score | log2(22/2470*10)=-3.48893561294738 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Fusion gene context | PubMed: FARP1 [Title/Abstract] AND NME1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Fusion neoantigen context | PubMed: FARP1 [Title/Abstract] AND NME1 [Title/Abstract] AND neoantigen [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | FARP1(98865667)-NME1(49237341), # samples:1 FARP1(98865667)-NME1(49233011), # samples:1 FARP1(98865667)-NME1(49237340), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | FARP1-NME1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FARP1-NME1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FARP1 | GO:0010923 | negative regulation of phosphatase activity | 19389623 |
Tgene | NME1 | GO:0001172 | transcription, RNA-templated | 19701182 |
Tgene | NME1 | GO:0030422 | production of siRNA involved in RNA interference | 19701182 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:98865667/chr17:49237341) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Amino Acid Sequences |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237341 | + | 1093 | 410 | 239 | 742 | 167 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237341 | + | 959 | 410 | 239 | 742 | 167 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237341 | + | 939 | 410 | 239 | 628 | 129 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237341 | + | 1843 | 410 | 785 | 426 | 119 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237341 | + | 796 | 410 | 239 | 742 | 167 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237341 | + | 1190 | 507 | 336 | 839 | 167 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237341 | + | 1056 | 507 | 336 | 839 | 167 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237341 | + | 1036 | 507 | 336 | 725 | 129 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237341 | + | 1940 | 507 | 882 | 523 | 119 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237341 | + | 893 | 507 | 336 | 839 | 167 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237341 | + | 1119 | 436 | 265 | 768 | 167 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237341 | + | 985 | 436 | 265 | 768 | 167 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237341 | + | 965 | 436 | 265 | 654 | 129 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237341 | + | 1869 | 436 | 811 | 452 | 119 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237341 | + | 822 | 436 | 265 | 768 | 167 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237341 | + | 890 | 207 | 36 | 539 | 167 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237341 | + | 756 | 207 | 36 | 539 | 167 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237341 | + | 736 | 207 | 36 | 425 | 129 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237341 | + | 1640 | 207 | 582 | 223 | 119 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237341 | + | 593 | 207 | 36 | 539 | 167 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237340 | + | 1093 | 410 | 239 | 742 | 167 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237340 | + | 959 | 410 | 239 | 742 | 167 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237340 | + | 939 | 410 | 239 | 628 | 129 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237340 | + | 1843 | 410 | 785 | 426 | 119 |
ENST00000595437 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237340 | + | 796 | 410 | 239 | 742 | 167 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237340 | + | 1190 | 507 | 336 | 839 | 167 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237340 | + | 1056 | 507 | 336 | 839 | 167 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237340 | + | 1036 | 507 | 336 | 725 | 129 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237340 | + | 1940 | 507 | 882 | 523 | 119 |
ENST00000376586 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237340 | + | 893 | 507 | 336 | 839 | 167 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237340 | + | 1119 | 436 | 265 | 768 | 167 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237340 | + | 985 | 436 | 265 | 768 | 167 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237340 | + | 965 | 436 | 265 | 654 | 129 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237340 | + | 1869 | 436 | 811 | 452 | 119 |
ENST00000319562 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237340 | + | 822 | 436 | 265 | 768 | 167 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000393196 | NME1 | chr17 | 49237340 | + | 890 | 207 | 36 | 539 | 167 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000336097 | NME1 | chr17 | 49237340 | + | 756 | 207 | 36 | 539 | 167 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000480143 | NME1 | chr17 | 49237340 | + | 736 | 207 | 36 | 425 | 129 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000511355 | NME1 | chr17 | 49237340 | + | 1640 | 207 | 582 | 223 | 119 |
ENST00000376581 | FARP1 | chr13 | 98865667 | + | ENST00000013034 | NME1 | chr17 | 49237340 | + | 593 | 207 | 36 | 539 | 167 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000595437 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.004359138 | 0.9956409 |
ENST00000595437 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.003887513 | 0.9961125 |
ENST00000595437 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.009027818 | 0.99097216 |
ENST00000595437 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.028309105 | 0.97169095 |
ENST00000595437 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.002479558 | 0.9975204 |
ENST00000376586 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.003445261 | 0.99655473 |
ENST00000376586 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.002795132 | 0.99720484 |
ENST00000376586 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.007158931 | 0.9928411 |
ENST00000376586 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.033667233 | 0.96633273 |
ENST00000376586 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.001796898 | 0.99820304 |
ENST00000319562 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.004068244 | 0.9959318 |
ENST00000319562 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.003785904 | 0.9962141 |
ENST00000319562 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.008181249 | 0.9918188 |
ENST00000319562 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.016296577 | 0.98370343 |
ENST00000319562 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.002571577 | 0.99742836 |
ENST00000376581 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.002671913 | 0.99732804 |
ENST00000376581 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.002475579 | 0.99752444 |
ENST00000376581 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.007428587 | 0.9925714 |
ENST00000376581 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.047890197 | 0.95210975 |
ENST00000376581 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237341 | + | 0.001373852 | 0.9986261 |
ENST00000595437 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.004359138 | 0.9956409 |
ENST00000595437 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.003887513 | 0.9961125 |
ENST00000595437 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.009027818 | 0.99097216 |
ENST00000595437 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.028309105 | 0.97169095 |
ENST00000595437 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.002479558 | 0.9975204 |
ENST00000376586 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.003445261 | 0.99655473 |
ENST00000376586 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.002795132 | 0.99720484 |
ENST00000376586 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.007158931 | 0.9928411 |
ENST00000376586 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.033667233 | 0.96633273 |
ENST00000376586 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.001796898 | 0.99820304 |
ENST00000319562 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.004068244 | 0.9959318 |
ENST00000319562 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.003785904 | 0.9962141 |
ENST00000319562 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.008181249 | 0.9918188 |
ENST00000319562 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.016296577 | 0.98370343 |
ENST00000319562 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.002571577 | 0.99742836 |
ENST00000376581 | ENST00000393196 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.002671913 | 0.99732804 |
ENST00000376581 | ENST00000336097 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.002475579 | 0.99752444 |
ENST00000376581 | ENST00000480143 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.007428587 | 0.9925714 |
ENST00000376581 | ENST00000511355 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.047890197 | 0.95210975 |
ENST00000376581 | ENST00000013034 | FARP1 | chr13 | 98865667 | + | NME1 | chr17 | 49237340 | + | 0.001373852 | 0.9986261 |
![]() |
Get the fusion protein sequences from here. |
Fusion protein sequence information is available in the fasta format. >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP |
Top |
Fusion Protein Breakpoint Sequences for FARP1-NME1 |
![]() |
Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Length(fusion protein) | BP in fusion protein | Peptide |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237340 | 207 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237340 | 410 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237340 | 436 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237340 | 507 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237341 | 207 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237341 | 410 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237341 | 436 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
FARP1 | chr13 | 98865667 | NME1 | chr17 | 49237341 | 507 | 57 | QMLDDTQEAFEVPASEDLLKEHYVDL |
Top |
Potential FusionNeoAntigen Information of FARP1-NME1 in HLA I |
![]() |
FARP1-NME1-NME2_98865667_49237341.msa | |
FARP1-NME1_98865667_49237340.msa |
![]() * We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5) |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA I | FusionNeoAntigen peptide | Binding score | Immunogenic score | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B45:01 | QEAFEVPAS | 0.9859 | 0.9854 | 6 | 15 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B50:02 | QEAFEVPAS | 0.9668 | 0.7995 | 6 | 15 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B18:01 | FEVPASEDL | 0.7254 | 0.952 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B39:13 | FEVPASEDL | 0.3976 | 0.8801 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B39:08 | FEVPASEDL | 0.3683 | 0.6733 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B40:04 | FEVPASEDL | 0.988 | 0.6989 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B18:05 | FEVPASEDL | 0.7254 | 0.952 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B18:03 | FEVPASEDL | 0.6567 | 0.948 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B18:11 | FEVPASEDL | 0.5867 | 0.8543 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B39:31 | FEVPASEDL | 0.4546 | 0.883 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B39:02 | FEVPASEDL | 0.4245 | 0.8844 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B39:11 | FEVPASEDL | 0.3989 | 0.6713 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B41:03 | FEVPASEDL | 0.3798 | 0.5267 | 9 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B40:04 | FEVPASEDLL | 0.9442 | 0.6508 | 9 | 19 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-B40:04 | AFEVPASEDL | 0.3595 | 0.7528 | 8 | 18 |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 | HLA-A68:02 | EAFEVPASEDL | 0.9965 | 0.6673 | 7 | 18 |
Top |
Potential FusionNeoAntigen Information of FARP1-NME1 in HLA II |
![]() |
![]() * We used NetMHCIIpan v4.1 (%rank<0.5). |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA II | FusionNeoAntigen peptide | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
Top |
Fusion breakpoint peptide structures of FARP1-NME1 |
![]() * The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA. |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
1084 | DFCIQVGRTMANLE | FARP1 | NME1 | NME2 | chr13 | 98865667 | chr17 | 49237341 |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
7205 | QEAFEVPASEDLLK | FARP1 | NME1 | chr13 | 98865667 | chr17 | 49237340 | 436 |
Top |
Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of FARP1-NME1 |
![]() * We used Glide to predict the interaction between HLAs and neoantigens. |
HLA allele | PDB ID | File name | BPseq | Docking score | Glide score |
HLA-B14:02 | 3BVN | 1084 | DFCIQVGRTMANLE | -7.9962 | -8.1096 |
HLA-B14:02 | 3BVN | 1084 | DFCIQVGRTMANLE | -5.70842 | -6.74372 |
HLA-B52:01 | 3W39 | 1084 | DFCIQVGRTMANLE | -6.83737 | -6.95077 |
HLA-B52:01 | 3W39 | 1084 | DFCIQVGRTMANLE | -4.4836 | -5.5189 |
HLA-A11:01 | 4UQ2 | 1084 | DFCIQVGRTMANLE | -10.0067 | -10.1201 |
HLA-A11:01 | 4UQ2 | 1084 | DFCIQVGRTMANLE | -9.03915 | -10.0745 |
HLA-A24:02 | 5HGA | 1084 | DFCIQVGRTMANLE | -6.56204 | -6.67544 |
HLA-A24:02 | 5HGA | 1084 | DFCIQVGRTMANLE | -5.42271 | -6.45801 |
HLA-B44:05 | 3DX8 | 1084 | DFCIQVGRTMANLE | -7.85648 | -8.89178 |
HLA-B44:05 | 3DX8 | 1084 | DFCIQVGRTMANLE | -5.3978 | -5.5112 |
HLA-A02:01 | 6TDR | 1084 | DFCIQVGRTMANLE | -3.37154 | -4.40684 |
HLA-B14:02 | 3BVN | 7205 | QEAFEVPASEDLLK | -7.15543 | -7.26883 |
HLA-B14:02 | 3BVN | 7205 | QEAFEVPASEDLLK | -4.77435 | -5.80965 |
HLA-B52:01 | 3W39 | 7205 | QEAFEVPASEDLLK | -6.80875 | -6.92215 |
HLA-B52:01 | 3W39 | 7205 | QEAFEVPASEDLLK | -4.20386 | -5.23916 |
HLA-A11:01 | 4UQ2 | 7205 | QEAFEVPASEDLLK | -7.5194 | -8.5547 |
HLA-A11:01 | 4UQ2 | 7205 | QEAFEVPASEDLLK | -6.9601 | -7.0735 |
HLA-A24:02 | 5HGA | 7205 | QEAFEVPASEDLLK | -7.52403 | -7.63743 |
HLA-A24:02 | 5HGA | 7205 | QEAFEVPASEDLLK | -5.82433 | -6.85963 |
HLA-B27:05 | 6PYJ | 7205 | QEAFEVPASEDLLK | -3.28285 | -4.31815 |
HLA-B44:05 | 3DX8 | 7205 | QEAFEVPASEDLLK | -5.91172 | -6.94702 |
HLA-B44:05 | 3DX8 | 7205 | QEAFEVPASEDLLK | -4.24346 | -4.35686 |
Top |
Vaccine Design for the FusionNeoAntigens of FARP1-NME1 |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide sequence | FusionNeoAntigen RNA sequence |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 6 | 15 | QEAFEVPAS | CAGGAGGCATTTGAAGTTCCAGCTTCC |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 7 | 18 | EAFEVPASEDL | GAGGCATTTGAAGTTCCAGCTTCCGAAGATCTT |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 8 | 18 | AFEVPASEDL | GCATTTGAAGTTCCAGCTTCCGAAGATCTT |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 9 | 18 | FEVPASEDL | TTTGAAGTTCCAGCTTCCGAAGATCTT |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237340 | 9 | 19 | FEVPASEDLL | TTTGAAGTTCCAGCTTCCGAAGATCTTCTC |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237341 | 12 | 23 | GRTMANLERTF | CCAGCTTCCGAAGATCTTCTCAAGGAACACTAC |
FARP1-NME1 | chr13 | 98865667 | chr17 | 49237341 | 7 | 16 | FCIQVGRTM | GAGGCATTTGAAGTTCCAGCTTCCGAA |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide | FusionNEoAntigen RNA sequence |
Top |
Information of the samples that have these potential fusion neoantigens of FARP1-NME1 |
![]() |
Cancer type | Fusion gene | Hchr | Hbp | Henst | Tchr | Tbp | Tenst | Sample |
LGG | FARP1-NME1 | chr13 | 98865667 | ENST00000319562 | chr17 | 49237340 | ENST00000013034 | TCGA-DB-5275 |
Top |
Potential target of CAR-T therapy development for FARP1-NME1 |
![]() |
![]() * Minus value of BPloci means that the break point is located before the CDS. |
- In-frame and retained 'Transmembrane'. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
![]() * We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image. |
Hgene | Hchr | Hbp | Henst | Tgene | Tchr | Tbp | Tenst | DeepLoc result |
Top |
Related Drugs to FARP1-NME1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to FARP1-NME1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |